Exchange: NASDAQ·Updated 07:30 PM EST

AAPG News

News
all
press releases
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Sees Large Decrease in Short Interest
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) saw a significant decline in short interest in the month of October. As of October 30th, there was short interest totaling 9,125 shares, a decline of 49.8% from the October 15th total of 18,161 shares. Based on...
MarketBeat
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Sees Large Decrease in Short Interest
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) saw a significant decline in short interest in the month of October. As of October 30th, there was short interest totaling 9,125 shares, a decline of 49.8% from the October 15th total of 18,161 shares. Based on...
MarketBeat
More News
On Thursday, Ascentage Pharma Group (NASDAQ:AAPG) discussed quarterly financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensiveread more...
Benzinga
The average of price targets set by Wall Street analysts indicates a potential upside of 160.1% in Ascentage Pharma Group International - Unsponsored ADR (AAPG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks
The consensus price target hints at a 152.2% upside potential for Ascentage Pharma Group International - Unsponsored ADR (AAPG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - What's Next...
MarketBeat
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) was the recipient of a significant decrease in short interest in April. As of April 15th, there was short...
MarketBeat
Ascentage Pharma Group International (NASDAQ:AAPG) Sees Unusually-High Trading Volume - Should You Buy...
MarketBeat
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) has received an average rating of "Buy" from the seven brokerages that are presently covering the stock...
MarketBeat
Ascentage Pharma Group International (NASDAQ:AAPG) Trading Down 8.4% - What's Next...
MarketBeat
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - Here's Why...
MarketBeat

Advertisement|Remove ads.